Michael Robert A. has filed 30 insider transactions across 1 company since February 2023.
Most recent transaction: a tax payment of 36523 shares of AbbVie Inc. ($ABBV) on February 27, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | AbbVie Inc. | $ABBV | Michael Robert A. | CHAIRMAN OF THE BOARD AND CEO | F | Common Stock, $0.01 par value | 36523 | $232.08 | 178,737.0000 | 1,773,000,000 | 16.97% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Michael Robert A. | CHIEF EXECUTIVE OFFICER | A | Common Stock, $0.01 par value | 33833 | $0.00 | 166,654.0000 | 1,773,000,000 | 25.47% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Michael Robert A. | CHIEF EXECUTIVE OFFICER | A | Option (Right to Buy) | 81251 | $0.00 | 81,251.0000 | 1,773,000,000 | 9999.99% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Michael Robert A. | CHIEF EXECUTIVE OFFICER | A | Common Stock, $0.01 par value | 22124 | $0.00 | 215,260.0000 | 1,773,000,000 | 11.46% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Michael Robert A. | CHIEF EXECUTIVE OFFICER | A | Common Stock, $0.01 par value | 14452 | $0.00 | 193,136.0000 | 1,773,000,000 | 8.09% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Michael Robert A. | CHIEF EXECUTIVE OFFICER | A | Common Stock, $0.01 par value | 12030 | $0.00 | 178,684.0000 | 1,773,000,000 | 7.22% | 0.00% |
| Feb. 28, 2025 | AbbVie Inc. | $ABBV | Michael Robert A. | CHIEF EXECUTIVE OFFICER | F | Common Stock, $0.01 par value | 27186 | $205.02 | 132,821.0000 | 1,773,000,000 | 16.99% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Michael Robert A. | CHIEF EXECUTIVE OFFICER | A | Common Stock, $0.01 par value | 24732 | $0.00 | 123,377.0000 | 1,773,000,000 | 25.07% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Michael Robert A. | CHIEF EXECUTIVE OFFICER | A | Common Stock, $0.01 par value | 10146 | $0.00 | 133,523.0000 | 1,773,000,000 | 8.22% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Michael Robert A. | CHIEF EXECUTIVE OFFICER | A | Common Stock, $0.01 par value | 12030 | $0.00 | 145,553.0000 | 1,773,000,000 | 9.01% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Michael Robert A. | CHIEF EXECUTIVE OFFICER | A | Common Stock, $0.01 par value | 14454 | $0.00 | 160,007.0000 | 1,773,000,000 | 9.93% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Michael Robert A. | CHIEF EXECUTIVE OFFICER | A | Option (Right to Buy) | 83333 | $0.00 | 83,333.0000 | 1,773,000,000 | 9999.99% | 0.00% |
| Feb. 29, 2024 | AbbVie Inc. | $ABBV | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | M | Option (Right to Buy) | 10140 | $54.86 | 0.0000 | 1,773,000,000 | 100.00% | 0.00% |
| Feb. 29, 2024 | AbbVie Inc. | $ABBV | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | M | Common Stock, $0.01 par value | 11420 | $61.36 | 157,384.0000 | 1,773,000,000 | 7.82% | 0.00% |
| Feb. 29, 2024 | AbbVie Inc. | $ABBV | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | M | Common Stock, $0.01 par value | 10140 | $54.86 | 167,524.0000 | 1,773,000,000 | 6.44% | 0.00% |
| Feb. 29, 2024 | AbbVie Inc. | $ABBV | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | S | Common Stock, $0.01 par value | 21560 | $176.44 | 145,964.0000 | 1,773,000,000 | 12.87% | 0.00% |
| Feb. 29, 2024 | AbbVie Inc. | $ABBV | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | S | Common Stock, $0.01 par value | 47319 | $176.46 | 98,645.0000 | 1,773,000,000 | 32.42% | 0.00% |
| Feb. 29, 2024 | AbbVie Inc. | $ABBV | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | M | Option (Right to Buy) | 11420 | $61.36 | 0.0000 | 1,773,000,000 | 100.00% | 0.00% |
| Feb. 28, 2024 | AbbVie Inc. | $ABBV | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | F | Common Stock, $0.01 par value | 37638 | $178.99 | 145,964.0000 | 1,773,000,000 | 20.50% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | A | Common Stock, $0.01 par value | 49565 | $0.00 | 148,210.0000 | 1,773,000,000 | 50.25% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | A | Common Stock, $0.01 par value | 13216 | $0.00 | 161,426.0000 | 1,773,000,000 | 8.92% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | A | Common Stock, $0.01 par value | 10146 | $0.00 | 171,572.0000 | 1,773,000,000 | 6.29% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | A | Common Stock, $0.01 par value | 12030 | $0.00 | 183,602.0000 | 1,773,000,000 | 7.01% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | A | Option (Right to Buy) | 59888 | $0.00 | 59,888.0000 | 1,773,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2023 | AbbVie Inc. | $ABBV | Michael Robert A. | VICE CHAIRMAN | F | Common Stock, $0.01 par value | 48335 | $154.28 | 98,645.0000 | 1,778,000,000 | 32.89% | 0.00% |
| Feb. 16, 2023 | AbbVie Inc. | $ABBV | Michael Robert A. | VICE CHAIRMAN | A | Option (Right to Buy) | 45577 | $0.00 | 45,577.0000 | 1,778,000,000 | 9999.99% | 0.00% |
| Feb. 16, 2023 | AbbVie Inc. | $ABBV | Michael Robert A. | VICE CHAIRMAN | A | Common Stock, $0.01 par value | 10148 | $0.00 | 146,980.0000 | 1,778,000,000 | 7.42% | 0.00% |
| Feb. 16, 2023 | AbbVie Inc. | $ABBV | Michael Robert A. | VICE CHAIRMAN | A | Common Stock, $0.01 par value | 13218 | $0.00 | 136,832.0000 | 1,778,000,000 | 10.69% | 0.00% |
| Feb. 16, 2023 | AbbVie Inc. | $ABBV | Michael Robert A. | VICE CHAIRMAN | A | Common Stock, $0.01 par value | 16220 | $0.00 | 123,614.0000 | 1,778,000,000 | 15.10% | 0.00% |
| Feb. 16, 2023 | AbbVie Inc. | $ABBV | Michael Robert A. | VICE CHAIRMAN | A | Common Stock, $0.01 par value | 69517 | $0.00 | 107,394.0000 | 1,778,000,000 | 183.53% | 0.00% |